Pharmacogenomics
Pharmacogenomics is the study of the role of genetics in drug response. It deals with the effect of genetic variation on drug response in patients by associating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Pharmacogenetics focuses on single drug-gene interactions. It helps in Improve drug safety, and reduce ADRs,Tailor treatments to meet patients' unique genetic pre-disposition, identifying optimal dosing.
- Genome sequencing
- Clinical Pharmacogenomics
- Genomics for optimized medical prescription
- More accurate methods of determining appropriate drug dosages
- Advanced screening for disease
Related Conference of Pharmacogenomics
17th International Conference on Tissue Science and Regenerative Medicine
Pharmacogenomics Conference Speakers
Recommended Sessions
- Case Reports
- Cancer Metabolomics
- Computational Methodologies
- Edibilomics
- Enzyme Nanotechnology
- Epigenomics and Epigenetics
- Lipidomics
- Mass Spectrometry based Metabolomics
- Metabolomics
- Metabolomics in Precision Medicine
- Microbial Metabolism
- Molecular Medicine and Diagnostics
- Next-generation sequencing
- Pharmacogenomics
- Proteomics
- Recent Advancements in Metabolomics
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- 3D Structure Determination - Structural Biology-2025 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2025 (France)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- AI & Computational Structural Biology - Structural Biology-2025 (France)
- Biochemistry and Biophysics - Structural Biology-2025 (France)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology-2025 (France)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology-2025 (France)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene Regulation and Cell Signaling - Structural Biology 2025 (Germany)
- Hybrid Approaches for Structure Prediction - Structural Biology-2025 (France)
- Hybrid Approaches in Structure Prediction - Structural Biology 2025 (Germany)
- Membrane Proteins and Receptors - Structural Biology-2025 (France)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular Biology Techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology-2025 (France)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology-2025 (France)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Bioinformatics and Computational Biology - Structural Biology-2025 (France)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology-2025 (France)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Structural Virology - Structural Biology-2025 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2025 (France)
- Structure-Based Drug Discovery - Structural Biology-2025 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2025 (France)
- Structure-Function Relationships - Structural Biology-2025 (France)
- The Structural Basis of Disease - Structural Biology-2025 (France)